Fox2 Now reports that University of Washington School of Medicine and Siteman Cancer Center are conducting a landmark study in the fight against prostate cancer—the results could be promising. The trial centers on a lead investigator’s focus on prostate cancer antigen vaccine. Follow the link to read about how a patient is faring quite well.

Lead Research/Investigator

Dr. Russell Pachynski

Source: FOX 2 Now

Pin It on Pinterest